Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merit Melin

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
The Journal of Infectious Diseases|November 17, 2007
Antibodies to pneumococcal surface protein A families 1 and 2 in serum and saliva of children and the risk of pneumococcal acute otitis mediaBirgit Simell, Merit Melin, Mika Lahdenkari, et al.
European Journal of Immunology|March 21, 2022
Neutralizing antibodies to SARS-CoV-2 Omicron variant after third mRNA vaccination in health care workers and elderly subjectsAnu Haveri, Anna Solastie, Nina Ekström, et al.
The Journal of Infectious Diseases|February 25, 2016
Similar Antibody Levels in 3-Year-Old Children Vaccinated Against Measles, Mumps, and Rubella at the Age of 12 Months or 18 MonthsMia Kontio, Arto A Palmu, Ritva K Syrjänen, et al.
European Journal of Immunology|September 28, 2021
Persistence of neutralizing antibodies a year after SARS-CoV-2 infection in humansAnu Haveri, Nina Ekström, Anna Solastie, et al.
Infection and Immunity|March 3, 2010
Interaction of pneumococcal histidine triad proteins with human complementMerit Melin, Emmanuel Di Paolo, Leena Tikkanen, et al.
Vaccine|February 25, 2026
Immune responses following sequential mRNA booster doses targeting the SARS-CoV-2 omicron variants in immunocompromised individuals - A 3.5-year follow-upNina Ekström, Oona Liedes, Saimi Vara, et al.
Frontiers in Immunology|May 26, 2023
T cell immunity following COVID-19 vaccination in adult patients with primary antibody deficiency - a 22-month follow-upAntti Hurme, Pinja Jalkanen, Minna Marttila-Vaara, et al.
Microbiology Spectrum|November 17, 2021
A Highly Sensitive and Specific SARS-CoV-2 Spike- and Nucleoprotein-Based Fluorescent Multiplex Immunoassay (FMIA) to Measure IgG, IgA, and IgM Class AntibodiesAnna Solastie, Camilla Virta, Anu Haveri, et al.
Journal of Immunological Methods|June 24, 2018
Comparison of serological assays using pneumococcal proteins or polysaccharides for detection of Streptococcus pneumoniae infection in children with community-acquired pneumoniaIgor C Borges, Dafne C Andrade, Nina Ekström, et al.
Vaccines|March 28, 2024
Hybrid Immunity Improves the Immune Response after the Fourth COVID-19 Vaccine Dose in Individuals with Medical Conditions Predisposing to Severe COVID-19Nina Ekström, Tuija M Leino, Aapo Juutinen, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
The Journal of Infectious Diseases|November 17, 2007
Antibodies to pneumococcal surface protein A families 1 and 2 in serum and saliva of children and the risk of pneumococcal acute otitis mediaBirgit Simell, Merit Melin, Mika Lahdenkari, et al.
European Journal of Immunology|March 21, 2022
Neutralizing antibodies to SARS-CoV-2 Omicron variant after third mRNA vaccination in health care workers and elderly subjectsAnu Haveri, Anna Solastie, Nina Ekström, et al.
The Journal of Infectious Diseases|February 25, 2016
Similar Antibody Levels in 3-Year-Old Children Vaccinated Against Measles, Mumps, and Rubella at the Age of 12 Months or 18 MonthsMia Kontio, Arto A Palmu, Ritva K Syrjänen, et al.
European Journal of Immunology|September 28, 2021
Persistence of neutralizing antibodies a year after SARS-CoV-2 infection in humansAnu Haveri, Nina Ekström, Anna Solastie, et al.
Infection and Immunity|March 3, 2010
Interaction of pneumococcal histidine triad proteins with human complementMerit Melin, Emmanuel Di Paolo, Leena Tikkanen, et al.
Vaccine|February 25, 2026
Immune responses following sequential mRNA booster doses targeting the SARS-CoV-2 omicron variants in immunocompromised individuals - A 3.5-year follow-upNina Ekström, Oona Liedes, Saimi Vara, et al.
Frontiers in Immunology|May 26, 2023
T cell immunity following COVID-19 vaccination in adult patients with primary antibody deficiency - a 22-month follow-upAntti Hurme, Pinja Jalkanen, Minna Marttila-Vaara, et al.
Microbiology Spectrum|November 17, 2021
A Highly Sensitive and Specific SARS-CoV-2 Spike- and Nucleoprotein-Based Fluorescent Multiplex Immunoassay (FMIA) to Measure IgG, IgA, and IgM Class AntibodiesAnna Solastie, Camilla Virta, Anu Haveri, et al.
Journal of Immunological Methods|June 24, 2018
Comparison of serological assays using pneumococcal proteins or polysaccharides for detection of Streptococcus pneumoniae infection in children with community-acquired pneumoniaIgor C Borges, Dafne C Andrade, Nina Ekström, et al.
Vaccines|March 28, 2024
Hybrid Immunity Improves the Immune Response after the Fourth COVID-19 Vaccine Dose in Individuals with Medical Conditions Predisposing to Severe COVID-19Nina Ekström, Tuija M Leino, Aapo Juutinen, et al.
Pageof 4